Palantir CTO says AI researchers took up smoking to prove a hypothesis
Palantir Technologies (PLTR) CTO Shyam Sankar criticized AI hype, citing an unproven claim that some researchers started smoking, believing AI will cure cancer before cigarettes harm them. Sankar warned of 'mass psychosis' around AI, urging focus on practical applications. PLTR stock traded around $208.81 during the report. The article advises investors to prioritize measurable business metrics over speculative AI promises.
How this was made

The 30-second read
Why it matters
The remarks provide a fresh executive perspective but lack material operational impact; they may cause modest short‑term stock pressure.
Market read
Executive commentary on AI hype could slightly affect Palantir's stock sentiment but is unlikely to drive major price moves.
What to watch
Palantir's recent contract wins and revenue growth may offset short‑term sentiment effects from the CTO's remarks.
Background
Palantir CTO Shyam Sankar appeared on CBS to criticize the AI hype culture, using a provocative anecdote about researchers smoking to signal belief.
Ticker impact
CTO Shyam Sankar publicly criticized AI hype, saying some researchers smoke to signal belief, potentially affecting investor sentiment toward Palantir.
likely pressure as the market prices in the CTO's criticism of AI hype
No concrete operational change, but executive commentary can sway sentiment, especially for a stock heavily tied to AI expectations.
Market effects
May temper broader AI‑related hype, but limited to Palantir-specific sentiment.
Minimal impact on US markets; no broader regional effect.
Low; commentary is company‑specific without macro implications.
Counterpoint
Investors could view the comment as a sign of confidence that Palantir's leadership is aware of hype and may steer the business toward tangible AI contracts.
Key entities
- companyPalantir Technologies
US‑listed data‑analytics firm (ticker PLTR) whose CTO made the comments.
- executiveShyam Sankar
Chief Technology Officer of Palantir, source of the commentary.


